Synamics Therapeutics
Albert J. Kooistra is a distinguished scientist with extensive experience in computational medicinal chemistry and cheminformatics. Currently serving as Co-Founder and Chief Scientific Officer at Synamics Therapeutics since August 2023, Albert holds an Associate Professorship at the University of Copenhagen while concurrently contributing as a Senior Scientific Expert at Kvantify since December 2022. Previous roles include Assistant Professor and Research Scientist at Vrije Universiteit Amsterdam and various visiting scientist positions across notable institutions. Albert's research has focused on protein-ligand interactions, drug design methodologies, and the development of novel computational techniques for structure-based drug discovery. Albert earned a PhD in Computational Medicinal Chemistry from Vrije Universiteit Amsterdam, where a solid foundation in bioinformatics and telematics was established through earlier degrees.
This person is not in any teams
This person is not in any offices
Synamics Therapeutics
For 4 billion years, evolution has been the driving force of life and the greatest challenge in medicine. At Synamics, we’re taking a bold step forward. Instead of treating diseases as static issues, we’ve developed Dynaptive, a platform designed to anticipate how diseases will evolve and design therapies that stay ahead.